Top Industry Leaders in the Nasal Drug Delivery Market
Latest Nasal Drug Delivery Companies Update:
July 2023: Aptar Pharma, a leading provider of nasal spray pumps, acquires The Edge Innovations, gaining access to their innovative nasal delivery platform for small molecules.
June 2023: Sanofi collaborates with Enteris Biopharma to develop an intranasal formulation of their insulin product, potentially offering a non-invasive option for diabetes management.
September 2023: Aerosolve, a developer of dry powder nasal delivery devices, secures $40 million in Series B funding to advance their technology and expand market reach.
March 2023: Aptar Pharma invests $25 million in a new manufacturing facility dedicated to nasal drug delivery devices, highlighting their commitment to this growing market.
List of Nasal Drug Delivery Key companies in the market
- GlaxoSmithKline Plc. (UK)
- AstraZeneca (UK)
- Pfizer, Inc. (US)
- Becton Dickson & Company (US)
- Dr. Reddy’s Laboratories Ltd. (India)
- Sanofi-Aventis (UK)
- Merck & Co. (US)
- Cadila Pharmaceuticals (India)
- AEGIS THERAPEUTICS LLC (US)
- Novartis AG (UK)
- Johnson & Johnson Services, Inc (US)
- 3M COMPANY (US)